267 related articles for article (PubMed ID: 21463124)
1. Purine analog toxicity in patients with hairy cell leukemia.
Tadmor T
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():38-42. PubMed ID: 21463124
[TBL] [Abstract][Full Text] [Related]
2. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
Rucińska M; Machaczka M; Załuska A; Skotnicki AB
Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
[TBL] [Abstract][Full Text] [Related]
3. Cladribine in the treatment of hairy cell leukemia: initial and subsequent results.
Huynh E; Sigal D; Saven A
Leuk Lymphoma; 2009 Oct; 50 Suppl 1():12-7. PubMed ID: 19814692
[TBL] [Abstract][Full Text] [Related]
4. My treatment approach to hairy cell leukemia.
Naik RR; Saven A
Mayo Clin Proc; 2012 Jan; 87(1):67-76. PubMed ID: 22212971
[TBL] [Abstract][Full Text] [Related]
5. Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence.
Else M; Dearden CE; Matutes E; Forconi F; Lauria F; Ahmad H; Kelly S; Liyanage A; Ratnayake V; Shankari J; Whalley I; Catovsky D
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():75-8. PubMed ID: 21504288
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General Population.
Madanat YF; Rybicki L; Radivoyevitch T; Jagadeesh D; Dean R; Pohlman B; Kalaycio M; Sekeres MA; Smith MR; Hill BT
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):857-862. PubMed ID: 28778620
[TBL] [Abstract][Full Text] [Related]
7. Perspectives on purine analogues.
Cheson BD
Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S109-16. PubMed ID: 9137964
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up studies in hairy cell leukemia.
Grever MR; Zinzani PL
Leuk Lymphoma; 2009 Oct; 50 Suppl 1():23-6. PubMed ID: 19814694
[TBL] [Abstract][Full Text] [Related]
9. Neurotoxicity of purine analogs: a review.
Cheson BD; Vena DA; Foss FM; Sorensen JM
J Clin Oncol; 1994 Oct; 12(10):2216-28. PubMed ID: 7931492
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia following treatment with cladribine for hairy cell leukemia: a case report and review of the literature.
Hassan R; Gupta M; Kern W; Ozer H
Leuk Lymphoma; 2004 Oct; 45(10):2149-52. PubMed ID: 15370263
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hairy-cell leukemia: current views.
Tallman MS; Peterson LC; Hakimian D; Gillis S; Polliack A
Semin Hematol; 1999 Apr; 36(2):155-63. PubMed ID: 10319384
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of patients with hairy cell leukemia after cladribine treatment.
Saven A; Burian C; Koziol JA; Piro LD
Blood; 1998 Sep; 92(6):1918-26. PubMed ID: 9731048
[TBL] [Abstract][Full Text] [Related]
13. Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias.
Pott-Hoeck C; Hiddemann W
Ann Oncol; 1995 May; 6(5):421-33. PubMed ID: 7669706
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of patients with hairy cell leukemia in the south of Iran.
Dehghani M; Kashkooe A; Namdari N; Majidi R; Karimi M; Haghighat S; Rezvani A; Safari N
Expert Rev Hematol; 2023 Apr; 16(4):289-295. PubMed ID: 36709461
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of pentostatin compared with cladribine in the management of hairy cell leukemia in the United Kingdom.
Guest JF; Smith H; Sladkevicius E; Jackson G
Clin Ther; 2009; 31 Pt 2():2398-415. PubMed ID: 20110049
[TBL] [Abstract][Full Text] [Related]
16. Advances in the treatment of hairy-cell leukaemia.
Mey U; Strehl J; Gorschlüter M; Ziske C; Glasmacher A; Pralle H; Schmidt-Wolf I
Lancet Oncol; 2003 Feb; 4(2):86-94. PubMed ID: 12573350
[TBL] [Abstract][Full Text] [Related]
17. Long-term results for pentostatin and cladribine treatment of hairy cell leukemia.
Dearden CE; Else M; Catovsky D
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():21-4. PubMed ID: 21599603
[TBL] [Abstract][Full Text] [Related]
18. Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.
Else M; Ruchlemer R; Osuji N; Del Giudice I; Matutes E; Woodman A; Wotherspoon A; Swansbury J; Dearden C; Catovsky D
Cancer; 2005 Dec; 104(11):2442-8. PubMed ID: 16245328
[TBL] [Abstract][Full Text] [Related]
19. The optimal management of hairy cell leukaemia.
Gollard R; Lee TC; Piro LD; Saven A
Drugs; 1995 Jun; 49(6):921-31. PubMed ID: 7543840
[TBL] [Abstract][Full Text] [Related]
20. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias.
Cheson BD; Vena DA; Barrett J; Freidlin B
J Clin Oncol; 1999 Aug; 17(8):2454-60. PubMed ID: 10561309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]